Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cell Procurement

Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation

Bone Marrow Transplantation volume 38, pages 609–614 (2006)Cite this article

Abstract

To reduce costs and avoid inconvenient overtime work, our institution changed policy in September 2000 so that autologous stem cell apheresis products were stored overnight before cryopreservation rather than immediately processed. This retrospective review was conducted to evaluate the possible impact of this policy change on hematopoietic engraftment following autologous stem cell transplantation (ASCT). In total, 229 consecutive lymphoma patients who underwent a single, unpurged ASCT in Calgary between January 1995 and November 2003 were evaluated. Of these patients, 131 patients' autografts underwent immediate processing and cryopreservation before September 2000, and 98 patients' autografts underwent next-day cryopreservation after overnight storage following this date. Results of univariate and multivariate analyses demonstrated no adverse effect of overnight storage before cryopreservation on the number of days to initial engraftment of platelets or neutrophils, on the proportion of patients with low blood counts 6 months post-ASCT, or on lymphoma relapse rates or overall survival post-ASCT. These data suggest that overnight storage of the autograft before cryopreservation does not adversely affect graft viability or influence long-term disease status, and support the continued use of overnight storage of stem cells before cryopreservation as a convenient, cost reduction measure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Stewart DA, Guo D, Luider J, Auer I, Klassen J, Ching E et al. Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose. Bone Marrow Transplant 1999; 23: 1237–1243.

    Article  CAS  Google Scholar 

  2. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C . Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360–1377.

    Article  CAS  Google Scholar 

  3. Jestice HK, Scott MA, Ager S, Tolliday BH, Marcus RE . Liquid storage of peripheral blood progenitor cells for transplantation. Bone Marrow Transplant 1994; 14: 991–994.

    CAS  Google Scholar 

  4. Hechler G, Weide R, Heymanns J, Koppler H, Havemann K . Storage of noncryopreserved periphered blood stem cells for transplantation. Ann Hematol 1996; 72: 303–306.

    Article  CAS  Google Scholar 

  5. Pettengell R, Woll PJ, O'Connor DA, Dexter TM, Testa NG . Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time. Bone Marrow Transplant 1994; 14: 703–706.

    CAS  Google Scholar 

  6. Beaujean F, Pico J, Norol F, Divine M, Le Forestier C, Duedari N . Characteristics of peripheral blood progenitor cells frozen after 24 h of liquid storage. J Hematother 1996; 5: 681–686.

    Article  CAS  Google Scholar 

  7. de Kreuk AM, Jonkhoff AR, Zevenbergen A, Hendriks EC, Schuurhuis GJ, Ossenkoppele GJ et al. Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days. Bone Marrow Transplant 2001; 28: 145–155.

    Article  CAS  Google Scholar 

  8. Sugrue MW, Hutcheson CE, Fisk DD, Roberts CG, Mageed A, Wingard JR et al. The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost. J Hematother 1998; 7: 431–436.

    Article  CAS  Google Scholar 

  9. Lazarus HM, Pecora AL, Shea TC, Koc ON, White JM, Gabriel DA et al. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome. Bone Marrow Transplant 2000; 25: 559–566.

    Article  CAS  Google Scholar 

  10. Meehan KR, Areman EM, Ericson SG, Matias C, Seifeldin R, Schulman K . Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs. J Hematother Stem Cell Res 2000; 9: 767–771.

    Article  CAS  Google Scholar 

  11. Magrin S, Gentile S, Santoro A, Indovina A, Scime R, Hauser D et al. Collection, processing and storage of peripheral blood stem cells (PBSC). Haematologica 1991; 76 (Suppl 1): 55–57.

    PubMed  Google Scholar 

  12. Reiffers J, Cailliot C, Dazey B, Attal M, Caraux J, Boiron JM . Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34-positive cells. Lancet 1999; 354: 1092–1093.

    Article  CAS  Google Scholar 

  13. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001–3007.

    CAS  Google Scholar 

  14. Stewart DA, Guo D, Luider J, Auer I, Klassen J, Morris D et al. A low CD34+ cell dose predicts relapse and death early following autologous blood stem cell transplantation. Hematol 2001; 6: 19–27.

    Article  CAS  Google Scholar 

  15. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961–3969.

    CAS  Google Scholar 

  16. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favourable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588–596.

    CAS  Google Scholar 

  17. Gandhi MK, Jestice K, Scott MA, Bloxham D, Bass G, Marcus RE . The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant 1999; 23: 9–13.

    Article  CAS  Google Scholar 

  18. Koc ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G et al. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant 1998; 21: 337–343.

    Article  CAS  Google Scholar 

  19. Friedman J, Lazarus HM, Koc ON . Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplant 2000; 26: 831–836.

    Article  CAS  Google Scholar 

  20. Widmer L, Pichert G, Jost LM, Stahel RA . Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells. Blood 1996; 88: 3166–3175.

    CAS  Google Scholar 

Download references

Acknowledgements

We thank Maggie Yang and Jan McLaughlin for database management, Susan Berrigan from blood bank who supplied data, policies and procedures and Dr Karen Kopciuk and Thomas Speidel for statistical analysis.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada

    M D Parkins, N Bahlis, C Brown, L Savoie, J A Russell & D A Stewart

  2. Department of Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada

    N Bahlis, C Brown, L Savoie, A Chaudhry, J A Russell & D A Stewart

Authors
  1. M D Parkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Bahlis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Savoie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Chaudhry
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J A Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D A Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D A Stewart.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parkins, M., Bahlis, N., Brown, C. et al. Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation. Bone Marrow Transplant 38, 609–614 (2006). https://doi.org/10.1038/sj.bmt.1705501

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705501

Keywords

Search

Advanced search

Quick links